Scandion Oncology (Sweden) Price on September 11, 2023

If you're considering investing in Scandion Stock, it is important to understand the factors that can impact its price. Scandion Oncology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17 % return per unit of risk over the last 3 months. Scandion Oncology AS exposes fifteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scandion Oncology's Risk Adjusted Performance of (0.14), coefficient of variation of (572.24), and Variance of 30.58 to confirm the risk estimate we provide.
  
Scandion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1748

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSCOL

Estimated Market Risk

 5.53
  actual daily
49
51% of assets are more volatile

Expected Return

 -0.97
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average Scandion Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scandion Oncology by adding Scandion Oncology to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Price Boundaries

Scandion Oncology Period Price Range

Low
January 22, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Scandion Oncology AS cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Scandion Oncology January 22, 2025 Market Strength

Market strength indicators help investors to evaluate how Scandion Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scandion Oncology shares will generate the highest return on investment. By undertsting and applying Scandion Oncology stock market strength indicators, traders can identify Scandion Oncology AS entry and exit signals to maximize returns

Scandion Oncology Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Scandion Oncology's price direction in advance. Along with the technical and fundamental analysis of Scandion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Scandion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Scandion Stock Analysis

When running Scandion Oncology's price analysis, check to measure Scandion Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandion Oncology is operating at the current time. Most of Scandion Oncology's value examination focuses on studying past and present price action to predict the probability of Scandion Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandion Oncology's price. Additionally, you may evaluate how the addition of Scandion Oncology to your portfolios can decrease your overall portfolio volatility.